Connor, Clark & Lunn Investment Management Ltd.
Position in IRTC — iRhythm Holdings, Inc.
CIK 1596800
VANCOUVER, A1
Position in IRTC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,033,250
+$35,576 QoQ
Shares Held
42,314
-0.1% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#93
of 304 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IRTC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. IRTC ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
869,131 | $78,864,946 | |
| 2 | BSX |
Boston Scientific Corp
|
1,467,148 | $62,617,875 | |
| 3 | PHG |
Koninklijke Philips NV
|
563,724 | $15,327,654 | |
| 4 | SNN |
Smith & Nephew PLC
|
487,774 | $14,052,767 | |
| 5 | NVCR |
NovoCure Ltd
|
661,280 | $10,018,391 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
This page
|
42,314 | $5,033,250 | |
| 7 | AXGN |
Axogen, Inc.
|
67,118 | $3,100,180 | |
| 8 | VREX |
Varex Imaging Corp
|
293,435 | $3,060,526 |
All Filings in IRTC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,033,250 | 42,314 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,997,674 | 42,346 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,473,417 | 42,118 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $8,825,838 | 51,316 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,302,446 | 53,926 | Shares | Sole | 2025-08-07 | |
| 2023-06-30 | $1,111,112 | 10,651 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $810,660 | 6,536 | Shares | Sole | 2023-05-10 | |
| 2021-03-31 | $1,425,536 | 10,266 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||